271 related articles for article (PubMed ID: 19010839)
1. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA
Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839
[TBL] [Abstract][Full Text] [Related]
2. Endosialin: a novel malignant cell therapeutic target for neuroblastoma.
Rouleau C; Smale R; Sancho J; Fu YS; Kurtzberg L; Weber W; Kruger A; Jones C; Roth S; Bormann C; Dunham S; Krumbholz R; Curiel M; Wallar G; Mascarello J; Campos-Rivera J; Horten B; Schmid S; Miller G; Teicher BA
Int J Oncol; 2011 Oct; 39(4):841-51. PubMed ID: 21701770
[TBL] [Abstract][Full Text] [Related]
3. Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization.
Bagley RG; Honma N; Weber W; Boutin P; Rouleau C; Shankara S; Kataoka S; Ishida I; Roberts BL; Teicher BA
Microvasc Res; 2008 Nov; 76(3):180-8. PubMed ID: 18761022
[TBL] [Abstract][Full Text] [Related]
4. Endosialin is expressed in high grade and advanced sarcomas: evidence from clinical specimens and preclinical modeling.
Rouleau C; Smale R; Fu YS; Hui G; Wang F; Hutto E; Fogle R; Jones CM; Krumbholz R; Roth S; Curiel M; Ren Y; Bagley RG; Wallar G; Miller G; Schmid S; Horten B; Teicher BA
Int J Oncol; 2011 Jul; 39(1):73-89. PubMed ID: 21537839
[TBL] [Abstract][Full Text] [Related]
5. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells.
Christian S; Winkler R; Helfrich I; Boos AM; Besemfelder E; Schadendorf D; Augustin HG
Am J Pathol; 2008 Feb; 172(2):486-94. PubMed ID: 18187565
[TBL] [Abstract][Full Text] [Related]
6. Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies.
Rouleau C; Gianolio DA; Smale R; Roth SD; Krumbholz R; Harper J; Munroe KJ; Green TL; Horten BC; Schmid SM; Teicher BA
Mol Cancer Ther; 2015 Sep; 14(9):2081-9. PubMed ID: 26184481
[TBL] [Abstract][Full Text] [Related]
7. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
8. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
[TBL] [Abstract][Full Text] [Related]
9. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target.
Jin Z; Lahat G; Korchin B; Nguyen T; Zhu QS; Wang X; Lazar AJ; Trent J; Pollock RE; Lev D
Clin Cancer Res; 2008 Aug; 14(16):5033-42. PubMed ID: 18698021
[TBL] [Abstract][Full Text] [Related]
10. Expression of stromal cell markers in distinct compartments of human skin cancers.
Huber MA; Kraut N; Schweifer N; Dolznig H; Peter RU; Schubert RD; Scharffetter-Kochanek K; Pehamberger H; Garin-Chesa P
J Cutan Pathol; 2006 Feb; 33(2):145-55. PubMed ID: 16420310
[TBL] [Abstract][Full Text] [Related]
11. Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma.
Guo Y; Hu J; Wang Y; Peng X; Min J; Wang J; Matthaiou E; Cheng Y; Sun K; Tong X; Fan Y; Zhang PJ; Kandalaft LE; Irving M; Coukos G; Li C
Eur J Cancer; 2018 Feb; 90():111-121. PubMed ID: 29304474
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin.
Dolznig H; Schweifer N; Puri C; Kraut N; Rettig WJ; Kerjaschki D; Garin-Chesa P
Cancer Immun; 2005 Aug; 5():10. PubMed ID: 16076089
[TBL] [Abstract][Full Text] [Related]
13. CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract][Full Text] [Related]
14. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
[TBL] [Abstract][Full Text] [Related]
15. Tumor endothelial marker 7 (TEM-7): a novel target for antiangiogenic therapy.
Bagley RG; Rouleau C; Weber W; Mehraein K; Smale R; Curiel M; Callahan M; Roy A; Boutin P; St Martin T; Nacht M; Teicher BA
Microvasc Res; 2011 Nov; 82(3):253-62. PubMed ID: 21958527
[TBL] [Abstract][Full Text] [Related]
16. Newer vascular targets: endosialin (review).
Teicher BA
Int J Oncol; 2007 Feb; 30(2):305-12. PubMed ID: 17203210
[TBL] [Abstract][Full Text] [Related]
17. Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.
Bakkum-Gamez JN; Aletti G; Lewis KA; Keeney GL; Thomas BM; Navarro-Teulon I; Cliby WA
Gynecol Oncol; 2008 Jan; 108(1):141-8. PubMed ID: 17988723
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Modak S; Kramer K; Gultekin SH; Guo HF; Cheung NK
Cancer Res; 2001 May; 61(10):4048-54. PubMed ID: 11358824
[TBL] [Abstract][Full Text] [Related]
19. Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells.
Thway K; Robertson D; Jones RL; Selfe J; Shipley J; Fisher C; Isacke CM
Br J Cancer; 2016 Aug; 115(4):473-9. PubMed ID: 27434038
[TBL] [Abstract][Full Text] [Related]
20. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.
Körner M; Waser B; Reubi JC
Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]